American HomePatient Inc. and its stockholders may be happy with a recent plan to emerge from bankruptcy, but its secured lenders aren't so sanguine about the deal. AHP will pay off its lenders while stockholders retain equity in the company, according to a bankruptcy plan approved by federal court May 15. The plan, which will allow Brentwood, TN-based AHP to come out of Chapter 11 bankruptcy, calls for the company to continue its business operations uninterrupted under its current management team, AHP says in a release. The durable medical equipment, respiratory and infusion company and its subsidiaries filed for reorganization bankruptcy last July. The plan was hotly contested in April hearings by secured lenders, who protested their treatment under it, notes The Tennessean. The U.S. Bankruptcy Court for the Middle District of Tennessee approved the plan, but the secured lenders still may appeal it, points out AHP, which has 287 locations in 35 states. And AHP reported promising earnings for the quarter ended March 31. The company saw net income of $4.3 million on revenues of $82.5 million, compared to a loss of $66.9 million on revenues of $79.8 million for the same quarter in 2002. The year-ago loss was mostly due to a change in accounting rules, the company notes.
The Department of Justice maintains that Bayer engaged in "private labeling" for Kaiser Permanente. Bayer gave Kaiser a low price and affixed slightly different labels to the products it sold the HMO - labels that allowed the drugmaker to avoid reporting the discounted Kaiser prices to the federal government. That enabled Bayer to evade paying some of its rebates to Medicaid, which are designed to ensure that the government receives the lowest drug price offered to other purchasers. Managed care plans are more successful than FFS providers at facilitating or encouraging hospice use. The finding suggests managed care plans are more successful than FFS providers at facilitating or encouraging hospice use, the JAMA study notes. While the high costs of end-of-life care give MCOs an incentive to transfer patients to the hospice benefit, the study found no evidence of inappropriate placement in hospice. To see the study abstract for free, go to http://jama.ama-assn.org/cgi/content/abstract/289/17/2238. Then-FI Blue Cross Blue Shield of Illinois failed to process all of CPC's claims for 1995 and therefore didn't reimburse the agency for all of its patients due to the faulty Provider Statistical & Reimbursement (PS&R) report, CPC argues in CPC v. Thompson (No. 01 C 5164). CPC's internal records showed it made 7,344 visits while BCBS IL paid it for only 5,769 visits, the agency claims in the suit. But the PRRB said the PS&R was the best evidence of CPC's 1995 visits, especially since the agency offered no explanation for why BCBS IL failed to pay the other claims. The court sides with the PRRB in its April 22 decision, deeming that CPC didn't bring forth enough evidence to prove its visit numbers over the PS&R numbers. CPC argued that BCBS IL's PS&R data should automatically be suspect because the FI was dismissed as a Medicare contractor due to claims fraud. However, the court notes those fraud allegations occurred in BCBS IL offices that didn't process CPC's claims, so the data still is reliable. Investors recently had been pressuring Gentiva management to use its high level of cash to make the stock buy-back (see Eli's HCW, Vol. XII, No. 17, Industry Notes). Visiting nurse revenues grew from $7.4 million to $7.6 million in that period. Medicare and Medicaid reimbursement rate changes adversely impacted earnings, Almost Family said.